Augmented and Virtual Reality for Preprocedural Planning in Hepatic Transarterial Interventional Oncology: A Pilot Study in 50 Cases.

Saad Abu Zahra¹, Matthew Antalek¹, Ashima Kundu¹, Arsalan Nadeem¹, Stefan Schenke², Kyle Finos³, Neil Chatterjee¹, Ulas Bagci¹, Robert J Lewandowski¹, Andrew C Gordon⁴

¹Department of Radiology, Northwestern University, Chicago IL.

²Visage Imaging Inc., San Diego, CA, USA.

³Department of Interventional Radiology, Weill Cornell Medicine, New York, NY, USA.

⁴Department of Radiology, Northwestern University, Chicago IL. Electronic address: andrew-gordon@fsm.northwestern.edu.

PubMed DOI

Abstract

PURPOSE: To evaluate the feasibility, usability, and perceived impact of augmented and virtual reality (AR/VR) for preprocedural planning in transarterial interventional oncology procedures, as assessed through structured operator surveys. MATERIALS AND METHODS: This IRB-approved, single-center pilot study was conducted over 1 year (September 2024-September 2025). Interventional radiologists used…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.